Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.80 | 1.29 | 0.49 |
Stocks | 99.21 | 99.21 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.24 | 21.62 |
Price to Book | 4.56 | 4.18 |
Price to Sales | 2.62 | 2.44 |
Price to Cash Flow | 18.48 | 17.30 |
Dividend Yield | 1.67 | 1.31 |
5 Years Earnings Growth | 13.55 | 13.34 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.57 | 94.93 |
Basic Materials | 0.33 | 1.66 |
Consumer Defensive | 0.06 | 3.50 |
Financial Services | 0.04 | 9.42 |
Number of long holdings: 194
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.46 | 811.81 | -0.86% | |
UnitedHealth | US91324P1021 | 6.37 | 605.87 | -1.43% | |
Novo Nordisk B | DK0062498333 | 5.00 | 756.3 | +0.04% | |
J&J | US4781601046 | 4.68 | 153.24 | +0.39% | |
AbbVie | US00287Y1091 | 4.08 | 170.35 | -0.43% | |
Merck&Co | US58933Y1055 | 3.52 | 98.50 | -0.08% | |
Novartis | CH0012005267 | 2.90 | 91.95 | 0.00% | |
Roche Holding Participation | CH0012032048 | 2.86 | 263.10 | +0.00% | |
Thermo Fisher Scientific | US8835561023 | 2.77 | 541.90 | +0.21% | |
AstraZeneca | GB0009895292 | 2.77 | 10,178.0 | +0.34% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust I Acc | 1.68B | 7.04 | 14.13 | 15.25 | ||
Legal General US Index Trust I Dist | 1.79B | 7.05 | 14.13 | 15.25 | ||
Legal General US Index Trust C Acc | 3.69B | 14.61 | 10.47 | 14.99 | ||
Legal General US Index Trust C Dist | 884.59M | 14.53 | 10.45 | 14.98 | ||
Legal General US Index Trust F Acc | 559.6K | 14.34 | 10.15 | 14.66 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review